PET Imaging for Gynecologic Malignancies
Copyright © 2021 Elsevier Inc. All rights reserved..
This review article summarizes the clinical applications of established and emerging PET tracers in the evaluation of the 5 most common gynecologic malignancies: endometrial, ovarian, cervical, vaginal, and vulvar cancers. Emphasis is given to 2-deoxy-2-[18F]fluoro-d-glucose as the most widely used and studied tracer, with additional clinical tracers also explored. The common imaging protocols are discussed, including standard dose ranges and uptake times, established roles, as well as the challenges and future directions of these imaging techniques. The key points are emphasized with images from selected cases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
---|---|
Enthalten in: |
Radiologic clinics of North America - 59(2021), 5 vom: 15. Sept., Seite 813-833 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Friedman, Saul N [VerfasserIn] |
---|
Links: |
---|
Themen: |
0Z5B2CJX4D |
---|
Anmerkungen: |
Date Completed 23.08.2021 Date Revised 23.08.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1016/j.rcl.2021.05.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329366599 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329366599 | ||
003 | DE-627 | ||
005 | 20231225204948.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.rcl.2021.05.011 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329366599 | ||
035 | |a (NLM)34392921 | ||
035 | |a (PII)S0033-8389(21)00072-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Friedman, Saul N |e verfasserin |4 aut | |
245 | 1 | 0 | |a PET Imaging for Gynecologic Malignancies |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.08.2021 | ||
500 | |a Date Revised 23.08.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
520 | |a This review article summarizes the clinical applications of established and emerging PET tracers in the evaluation of the 5 most common gynecologic malignancies: endometrial, ovarian, cervical, vaginal, and vulvar cancers. Emphasis is given to 2-deoxy-2-[18F]fluoro-d-glucose as the most widely used and studied tracer, with additional clinical tracers also explored. The common imaging protocols are discussed, including standard dose ranges and uptake times, established roles, as well as the challenges and future directions of these imaging techniques. The key points are emphasized with images from selected cases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Cervical cancer | |
650 | 4 | |a Endometrial cancer | |
650 | 4 | |a Ovarian cancer | |
650 | 4 | |a PET | |
650 | 4 | |a Vaginal cancer | |
650 | 4 | |a Vulvar cancer | |
650 | 7 | |a Radiopharmaceuticals |2 NLM | |
650 | 7 | |a Fluorodeoxyglucose F18 |2 NLM | |
650 | 7 | |a 0Z5B2CJX4D |2 NLM | |
700 | 1 | |a Itani, Malak |e verfasserin |4 aut | |
700 | 1 | |a Dehdashti, Farrokh |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Radiologic clinics of North America |d 1963 |g 59(2021), 5 vom: 15. Sept., Seite 813-833 |w (DE-627)NLM000103411 |x 1557-8275 |7 nnns |
773 | 1 | 8 | |g volume:59 |g year:2021 |g number:5 |g day:15 |g month:09 |g pages:813-833 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rcl.2021.05.011 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 59 |j 2021 |e 5 |b 15 |c 09 |h 813-833 |